trial present – MD Update

Special Section

An Astounding Day in Stroke Care

December 1, 2015January 20, 2017 Jennifer S. Newton Abou-Chebl, Abou-Chebl point, Alex Abou-Chebl, anti-coagulants, appendage, astound day, atrial fibrillation, baptist health, baptist neuroscience associate, blockage, blockage of an artery, blood clot, brain, brain tissue, category of stroke patient, clinical trial present overwhelm evidence, clot, day of fatalism, endovascular, endovascular therapy, endovascular treatment, endovascular treatment of stroke, fibrillation, guideline, hemorrhage, high risk of mortality, history of clinical medicine, improve stroke outcome, included patient, international stroke conference, interventional neurologist, intracerebral, intracerebral hemorrhage, ischemic, large vessel stroke, lead cause, lead cause of death, Louisville, major deficit, medical director of stroke, mortality, neurological outcome, neurologist, neuroscience, neuroscience associate, new standard, new standard of care, new treatment evolve, occlusion, onset, outcome, overwhelm benefit, retriever, risk of stroke, select patient, standard of care, stent, stent retriever, stroke, stroke account, stroke care, stroke conference, stroke mortality, stroke onset, stroke outcome, stroke patient, therapy, tissue, tPA, treatment evolve, trial present, type of stroke account, use of endovascular treatment, vessel stroke

LOUISVILLE The days of fatalism in stroke care are long gone, or at least they should be, according to Alex

Read more